MDClone, a digital health company, together with leading healthcare organizations from around the world, announced the founding of The Global Network - a research and knowledge sharing collaborative. The Global Network leverages the MDClone platform to democratize data by organizing complex patient information and protecting patient privacy with synthetic data. Addressing an important barrier in cross-institution collaboration, synthetic data will allow for robust analysis using data which contains no individual patient information. The MDClone platform offers a framework to better understand the health of patients and develop solutions for care delivery. Using the platform installed across The Global Network sites, members will develop solutions and explore ideas together to improve patient health.

 In its first year, The Global Network will focus on three pillars of research: health services, clinical medicine and precision medicine. Members will be able to conduct projects within multiple sites, including study design and replication, testing new approaches and partnering with external healthcare organizations. These projects can be conducted without sharing individual patient information, utilizing synthetic data generated by MDClone at each member site from over 30 million total patients within the network.

MDClone’s platform, already installed in numerous health systems, has yielded impressive results. The platform turns cycles of discovery from months and years to hours and days through self-service exploration and access to synthetic data without IRB approval. Examples of MDClone in action include building a program for managing the chronic kidney disease population at Intermountain Healthcare, a machine-learning model for predicting sepsis at Washington University School of Medicine in St. Louis, evaluating side effects of immunotherapy on oncology patients at Sheba Medical Center and optimizing insulin treatment for diabetic patients at Rambam Health Care Campus in Israel. Some of the first projects underway in The Global Network are focused on understanding treatments and outcomes for patients with COVID-19. The members will establish additional opportunities for working within The Global Network at its first meeting in Summer 2020.